NAV CANADA employees’ raise over $414,000 for cancer research at The Ottawa Hospital!
In their 9th year of supporting The Ottawa Hospital, NAV CANADA employees have had a profound impact on made-in-Ottawa cancer therapies that will revolutionize cancer treatment around the world. 2016 marked a record year with over $414,000 raised through generous employee giving, a golf tournament, and special events throughout the May and June. As a result, NAV CANADA employees' have reached a philanthropic giving milestone of over $2.8 million in nine years - all in support of ground-breaking cancer research at The Ottawa Hospital.
A cheque was presented to the Ottawa Hospital Foundation on June 17, at the NAV CANADA Employee Golf Tournament. (L to R: Kim Troutman, 2016 Campaign Chair and Vice President, Engineering; Andrea Timlin, Development Officer, The Ottawa Hospital Foundation, and Neil Wilson, NAV CANADA President and CEO.)
NAV CANADA employees have played a vital role in supporting Dr. John Bell, Senior Scientist, Cancer Therapeutics, and this team’s research in developing cancer fighting oncolytic viruses. These viruses represent one of the most promising new approaches for fighting cancer because they can attack tumours in multiple ways, they have very mild side effects and they can be easily customized for different kinds of cancer. Their support has seen the development of these oncolytic viruses, namely the Maraba virus, move from the research stage to the clinical trial stage.
Thank you, NAV CANADA, for your continued dedication and commitment to health care in our community!